Breakthroughs at IOR in the research for anti-metastatic therapies
The Molecular Oncology research group, led by Prof. Andrea Alimonti at the Institute of Oncology Research (IOR, affiliated with USI and part of Bios+), a member of the SenoTarg consortium, has uncovered a novel method using bioinformatics and artificial intelligence to selectively target and eliminate specific cells involved in metastasis. The Problem Metastasis, the spread…